Mani (MNICF) Research & Development: $0.0 Mil (TTM As of Feb. 2026)


MNICF Mani Inc MNICF
98 GF Score
Price $12.82
GF Value $15.94
! 6 Warning Signs
View Full Analysis

What is Mani Research & Development?

Mani MNICF 98 Research & Development is $0.0 Mil as of Feb. 2026. GuruFocus rates MNICF with a GF Score™ of 98/100 and a GF Value™ of $15.94. The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Mani's Research & Development for the three months ended in Feb. 2026 was $0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 was $0.0 Mil.

Mani  (OTCPK:MNICF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Mani Research & Development Related Terms

Mani Research & Development Historical Data

* Premium members only.

The historical data trend for Mani's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mani Research & Development Chart

Mani Annual Data
Trend Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23 Aug24 Aug25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Mani Quarterly Data
May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24 Nov24 Feb25 May25 Aug25 Nov25 Feb26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MNICF
98GF Score
Mani Inc MNICF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mani Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Feb. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.0 Mil mean?
Mani (MNICF) has a Research & Development of $0.0 Mil as of Feb. 2026. Research and development expense is the total cost for research and development activities. View historical data on Mani and its competitors.
Is Mani's Research & Development too high?
Mani's current Research & Development is $0.0 Mil. Overall, Mani has a GF Score™ of 98/100, reflecting its overall financial health beyond just this single metric.
How does Mani's Research & Development compare to ISRG and BDX?
Mani's Research & Development of $0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Devices & Instruments company?
A good Research & Development depends on the Medical Devices & Instruments industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Mani and its competitors. Mani's current Research & Development is $0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mani stock overvalued right now?
Mani (MNICF) has a current Research & Development of $0.0 Mil. The stock's GF Value™ is $15.94, compared to a current price of $12.82 — trading 19.6% below its estimated fair value. The current Research & Development is $0.0 Mil. Mani's overall GF Score™ is 98/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Mani (MNICF), the current Research & Development is $0.0 Mil as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Mani (MNICF) Overvalued in 2026?

Based on GuruFocus' analysis, Mani stock appears to be undervalued. The current stock price of $12.82 is trading 19.6% below its estimated GF Value™ of $15.94.

Key valuation signals for MNICF:

  • Research & Development: $0.0 Mil
  • GF Value™: $15.94 vs. price of $12.82 (19.6% below fair value)
  • GF Score™: 98/100 with 6 warning signs

No single metric tells the full story. See the MNICF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mani Business Description

Other Exchanges 7730:Japan
Address 8-3 Kogyodanchi, Tochigi, JPN
Mani Inc manufactures medical devices and dental instruments. It sells products in four categories: surgical instruments, ophthalmic instruments, suture needles, and dental instruments. Mani's surgical products include instruments such as staplers, vessel knives, and bone saws. Its ophthalmic instruments include a range of knives used during eye surgery and ophthalmic sutures. Mani's suture needles business includes a variety of taper point and cutting eyeless needles, which require suture attachment and sterilization by the customer, as well as stainless-steel eyed needles. The firm's dental instruments include endodontic instruments and accessories, root canal equipment, and finishing and polishing instruments.
98GF Score

Get the complete analysis for MNICF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$12.82
Price
$15.94
GF Value